Catalyst Wire Dossier Catalyst Wire Dossier

NK-1 anti-emetic medication (unnamed in report)

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NK-1 anti-emetic medication (unnamed in report), covering 2017-01-20 to 2017-01-20. Get the full timeline:

Most recent: Clinical Trial Update: Study Of An NK-1 Anti-Emetic Medication For The Prevention Of Post-Operative Nausea And Vomiting In Female Patients [Phase 2]

See pricing